Paris, France

Monsif Bouaboula

This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Sanofi. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monsif Bouaboula. Retrieved from https://idiyas.com/inventor/monsif-bouaboula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.2

ph-index = 5

Forward Citations = 35(Granted Patents)


Location History:

  • Bridegwater, NJ (US) (2021)
  • Paris, FR (2017 - 2022)
  • Cambridge, MA (US) (2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Monsif Bouaboula: Innovator in Cancer Treatment**

Introduction

Monsif Bouaboula is a prominent inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer. With a total of five patents to his name, Bouaboula exemplifies the spirit of innovation within the healthcare industry.

Latest Patents

Among his latest patents is a groundbreaking combination therapy that includes palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid. This invention focuses on its application for the treatment of various cancers, particularly breast cancer. Another important patent involves substituted 6,7-dihydro-5H-benzo[7]annulene compounds, which details processes for their preparation and therapeutic applications.

Career Highlights

Monsif Bouaboula currently works at Sanofi, a global leader in healthcare innovation. His work at Sanofi has allowed him to translate his inventive ideas into tangible therapies that have the potential to improve patient outcomes in the oncology space. His dedication to research and development has placed him at the forefront of cancer treatment innovation.

Collaborations

Bouaboula collaborates with talented colleagues, including Maurice Brollo and Victor Certal. These partnerships blend diverse expertise, fostering an environment where groundbreaking pharmacological research can thrive. Together, they work to advance novel therapeutic combinations and continue to push the boundaries of cancer treatment.

Conclusion

Monsif Bouaboula's contributions to the field of oncology underscore the importance of innovation in pharmaceuticals. With multiple patents reflecting his dedication to addressing complex health challenges, Bouaboula continues to be a key player in the quest for effective cancer therapies. His work not only enhances scientific knowledge but also has a profound impact on patients suffering from life-threatening conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…